Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nanobiotix S.A. - ADSs
(NQ:
NBTX
)
38.58
+0.79 (+2.08%)
Streaming Delayed Price
Updated: 3:20 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nanobiotix S.A. - ADSs
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Voting Rights and Shares Capital of the Company
July 30, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
June 05, 2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
June 02, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Joins the Euronext Tech Leaders Index
June 02, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Closing of Global Offering
May 26, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
May 22, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
May 21, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
May 21, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris
May 21, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Launch of Global Follow-On Offering
May 20, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
May 17, 2026
Data presented by Johnson & Johnson at the 2026 European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
May 04, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
April 20, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
April 07, 2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
March 31, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
March 30, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
March 26, 2026
Conference call and webcast scheduled for Wednesday, April 1st, 2026, at 8:00 am EDT / 2:00 pm CEST
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Statement Regarding Recent Media Speculation
March 25, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
March 12, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Participate in Investor Conferences in March
February 25, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
February 17, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
January 13, 2026
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
December 17, 2025
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
December 15, 2025
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
November 24, 2025
From
Nanobiotix S.A.
Via
GlobeNewswire
Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue
↗
November 24, 2025
It has grown wildly, and it could keep growing.
Via
The Motley Fool
Voting Rights and Shares Capital of the Company
November 14, 2025
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
November 13, 2025
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Participate in Jefferies London Healthcare Conference
November 11, 2025
From
Nanobiotix S.A.
Via
GlobeNewswire
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
November 11, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
